MiMedx Group (NASDAQ:MDXG – Get Rating) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. Separately, HC Wainwright increased their price target on shares of MiMedx Group from $8.00 to $9.50 in a research note on Wednesday, May 3rd. MiMedx Group […]
MiMedx Group (NASDAQ:MDXG – Get Rating) and ResMed (NYSE:RMD – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations. Insider & Institutional Ownership 56.6% of MiMedx Group shares are owned […]
MiMedx Group (NASDAQ:MDXG – Get Rating) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday. Separately, HC Wainwright upped their target price on shares of MiMedx Group from $8.00 to $9.50 in a report on Wednesday, May 3rd. MiMedx Group Trading Down 4.7 % Shares of […]
MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) traded down 4.7% during trading on Wednesday . The company traded as low as $5.69 and last traded at $5.71. 84,703 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 593,688 shares. The stock had previously closed at $5.99. Analysts Set […]
StockNews.com cut shares of MiMedx Group (NASDAQ:MDXG – Get Rating) from a strong-buy rating to a buy rating in a research note issued to investors on Friday. Separately, HC Wainwright increased their target price on MiMedx Group from $8.00 to $9.50 in a research note on Wednesday, May 3rd. MiMedx Group Stock Performance MDXG stock […]